Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Notes Payables: 2014-2018

Historic Notes Payables for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Dec 2018 value amounting to $47.6 million.

  • Ironwood Pharmaceuticals' Notes Payables rose 96.28% to $48.8 million in Q2 2019 from the same period last year, while for Jun 2019 it was $48.8 million, marking a year-over-year increase of 96.28%. This contributed to the annual value of $47.6 million for FY2018, which is N/A change from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Notes Payables stood at $47.6 million for FY2018, which was up 90.49% from $25.0 million recorded in FY2015.
  • In the past 5 years, Ironwood Pharmaceuticals' Notes Payables registered a high of $47.6 million during FY2018, and its lowest value of $11.3 million during FY2014.
  • For the 1-year period, Ironwood Pharmaceuticals' Notes Payables averaged around $47.6 million, with its median value being $47.6 million (2018).
  • Data for Ironwood Pharmaceuticals' Notes Payables shows a peak YoY surged of 121.74% (in 2015) over the last 5 years.
  • Over the past 3 years, Ironwood Pharmaceuticals' Notes Payables (Yearly) stood at $11.3 million in 2014, then soared by 121.74% to $25.0 million in 2015, then reached $47.6 million in 2018.